In vitro and in vivo antistaphylococcal activities of L-695,256, a carbapenem with high affinity for the penicillin-binding protein PBP 2a.
about
In vitro and in vivo properties of Ro 63-9141, a novel broad-spectrum cephalosporin with activity against methicillin-resistant staphylococciOxazolidinones: a reviewLysostaphin treatment of experimental methicillin-resistant Staphylococcus aureus aortic valve endocarditis.Antibiotic resistance versus small molecules, the chemical evolution.Efficacy of levofloxacin for experimental aortic-valve endocarditis in rabbits infected with viridans group streptococcus or Staphylococcus aureusIn vitro activity of cephalosporin RWJ-54428 (MC-02479) against multidrug-resistant gram-positive cocci.Vancomycin treatment failure associated with heterogeneous vancomycin-intermediate Staphylococcus aureus in a patient with endocarditis and in the rabbit model of endocarditis.Importance of penicillinase production for activity of penicillin alone or in combination with sulbactam in experimental endocarditis due to methicillin-resistant Staphylococcus aureusMethicillin resistance in staphylococci: molecular and biochemical basis and clinical implications.PBP 2a mutations producing very-high-level resistance to beta-lactams.Identification and phenotypic characterization of a beta-lactam-dependent, methicillin-resistant Staphylococcus aureus strainJumping the barrier to beta-lactam resistance in Staphylococcus aureus.Direct quantitation of the number of individual penicillin-binding proteins per cell in Escherichia coli.Penicillin-binding protein 2a of methicillin-resistant Staphylococcus aureus.In vitro activities of novel trans-3,5-disubstituted pyrrolidinylthio-1beta-methylcarbapenems with potent activities against methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa.In vivo activity of evernimicin (SCH 27899) against methicillin-resistant Staphylococcus aureus in experimental infective endocarditis.BAL9141, a novel extended-spectrum cephalosporin active against methicillin-resistant Staphylococcus aureus in treatment of experimental endocarditis.In vitro activity of S-3578, a new broad-spectrum cephalosporin active against methicillin-resistant staphylococci.Autolysis of methicillin-resistant Staphylococcus aureus is involved in synergism between imipenem and cefotiam.Pharmacokinetics in nonhuman primates of a prototype carbapenem active against methicillin-resistant Staphylococcus aureus.Therapeutic efficacy of BO-3482, a novel dithiocarbamate carbapenem, in mice infected with methicillin-resistant Staphylococcus aureus.In vitro evaluation of BO-3482, a novel dithiocarbamate carbapenem with activity against methicillin-resistant staphylococci.VraSR two-component regulatory system contributes to mprF-mediated decreased susceptibility to daptomycin in in vivo-selected clinical strains of methicillin-resistant Staphylococcus aureus.The management of infection and colonization due to methicillin-resistant Staphylococcus aureus: A CIDS/CAMM position paper.Evaluation of ceftobiprole in a rabbit model of aortic valve endocarditis due to methicillin-resistant and vancomycin-intermediate Staphylococcus aureus.In vitro activities of ME1036 (CP5609), a novel parenteral carbapenem, against methicillin-resistant staphylococci.
P2860
Q24550612-70E149C1-C2D9-46A8-8DE2-C49932A5DDCCQ28373208-36894E45-E0FB-4153-8D77-A4066CEDB96FQ28379547-F6EA6B8B-AC92-42C4-ACE4-818BC5926505Q30811036-B77267A4-F7FA-4621-AD81-48EAA54E4B7BQ33978084-B471A3F4-5B15-4A7A-B0C7-B37C2B7361B5Q34105195-97F02E9A-79BB-4936-B26B-B50D185B98AEQ34885043-B2CEE877-9479-4BD0-857B-90313DD83FDFQ35124432-80D602CF-86E9-4924-8F9D-1C56A01DDE37Q35376362-12AF611D-9954-4750-BFA8-F4A37593A863Q35547377-5475BC35-496A-411A-A1CE-CD9999F7D2C3Q35879071-8290655D-C727-4F62-AB43-2E963655817CQ35921792-C83162B4-C6C7-4C48-8E03-F68A21EF5B96Q36829678-34CFE1A3-E3E5-42CC-9697-4920E60C72F0Q38232037-98EEEEC2-5D28-4F5C-AF58-F860F813A781Q39472968-9E99003F-9276-4549-A525-51AF1765C333Q39475968-D99747C0-4BD2-4A14-BCE9-C064FC4D00BCQ39650937-4184A45F-AA15-41F3-AD8C-45E794C828C5Q39731843-B3D4A76A-F5CD-4936-9BC3-11F053B928A1Q39780911-B3378439-8B29-4D8A-80CC-9A25145D6D91Q39781719-10F46002-DFBE-46E7-9E40-04B37DC5B34AQ39785118-EC08BA3E-9AB5-4FB3-982C-078A03CAF9BBQ39785125-511DC89B-F15C-4874-AAA5-C906F4943D42Q40327375-2540431E-9FDC-465D-A28A-345EC1E89325Q40667218-DA68BC05-449F-4460-A02C-39CF57312837Q41092910-A8EC05AE-90F3-4EBF-9AA4-C3515A6E26CFQ41269617-94E69CE4-62DB-43D5-8198-C6463193798A
P2860
In vitro and in vivo antistaphylococcal activities of L-695,256, a carbapenem with high affinity for the penicillin-binding protein PBP 2a.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
1995年學術文章
@zh
1995年學術文章
@zh-hant
name
In vitro and in vivo antistaph ...... cillin-binding protein PBP 2a.
@en
In vitro and in vivo antistaph ...... cillin-binding protein PBP 2a.
@nl
type
label
In vitro and in vivo antistaph ...... cillin-binding protein PBP 2a.
@en
In vitro and in vivo antistaph ...... cillin-binding protein PBP 2a.
@nl
prefLabel
In vitro and in vivo antistaph ...... cillin-binding protein PBP 2a.
@en
In vitro and in vivo antistaph ...... cillin-binding protein PBP 2a.
@nl
P2860
P356
P1476
In vitro and in vivo antistaph ...... cillin-binding protein PBP 2a.
@en
P2093
H F Chambers
P2860
P304
P356
10.1128/AAC.39.2.462
P407
P577
1995-02-01T00:00:00Z